| Predicate |
Object |
| contentType |
Journal Article|Comment |
| endingPage |
1488 |
| issn |
0140-6736 |
| issueIdentifier |
10208 |
| pageRange |
1486-1488 |
| publicationName |
Lancet (London, England) |
| startingPage |
1486 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1022c9ebb40ee89dd45ec259146f708d
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_49d2bb1671bc205cba998e64abcfa82e |
| bibliographicCitation |
Ganesan C, Pao AC. Spironolactone plus patiromer: proceed with caution. The Lancet. 2019 Oct;394(10208):1486–8. doi: 10.1016/s0140-6736(19)32485-7. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36555ee751b8c6421ca48cfe7cd1e5d9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82710f82162163688026a9f27ab967a7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4050-9587 |
| date |
2019-10-26^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC9048092
https://pubmed.ncbi.nlm.nih.gov/31657725
https://doi.org/10.1016/s0140-6736%2819%2932485-7 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0140-6736
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Spironolactone plus patiromer: proceed with caution |
| discusses |
http://id.nlm.nih.gov/mesh/M000608356
http://id.nlm.nih.gov/mesh/M0017208
http://id.nlm.nih.gov/mesh/M0020352
http://id.nlm.nih.gov/mesh/M0027940 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D051436
http://id.nlm.nih.gov/mesh/D006973 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D018647
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D011108
http://id.nlm.nih.gov/mesh/D013148 |